Table 3.
Results and Analyses of Difference P3 Components
| Difference ERPs | Healthy Controls | aCSVD Patients | Statistics | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Fz | Cz | Pz | Fz | Cz | Pz | Group (F) | Group × Electrode (F) | ||
| P3dT | Amplitude (μV) | 8.917 | 12.517 | 11.780 | 5.732 | 7.022 | 7.498 | 10.940* | 3.716* |
| (5.986) | (5.907) | (5.478) | (3.519) | (3.783) | (3.870) | ||||
| Latency (ms) | 422.565 | 431.957 | 431.087 | 443.440 | 450.840 | 448.640 | 5.483* | 0.051 | |
| (28.452) | (28.067) | (24.459) | (42.352) | (33.417) | (46.663) | ||||
| P3dN | Amplitude (μV) | 10.363 | 13.284 | 11.551 | 7.082 | 8.317 | 7.461 | 13.388* | 2.048 |
| (4.360) | (4.979) | (5.172) | (3.786) | (3.489) | (3.436) | ||||
| Latency (ms) | 383.043 | 392.261 | 392.652 | 431.200 | 435.160 | 440.160 | 22.430** | 0.103 | |
| (32.802) | (33.509) | (36.381) | (47.439) | (47.910) | (49.328) | ||||
Notes: SD appeared in parenthesis of the mean; P3dT: target minus standard, P3dN: novel minus standard; *P < 0.05, **P < 0.001 by repeated-measures ANOVA (Bonferroni correction).